Barney Kent, CEO and Managing Director of Touch Medical Media, discusses the exciting new partnership with C3 and how the collaboration will produce valuable educational content for cardiologists and HCPs.
Barney Kent, C3 2019 – Partnership Between touchCARDIO and C3
Trending Topic
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Revascularization for patients with ischaemic left ventricular (LV) systolic dysfunction takes one of two forms - percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG), both of which have positives and negatives. STICH, published in 2011, analysed the role of CABG in patients with LV systolic dysfunction and looked at improvement of clinical outcomes in 1,212 patients from 22 countries across the world, optimised to either optimal medical therapy or optimal medical therapy plus CABG. REVIVED-BCIS2 in 2022 looked at 700 patients in the UK with a similar patient population of 35% ejection fraction or less, randomized to PCI or optimal medical therapy. This interview dives into their analysis of the results from these exciting trials and investigation into the discrepancies between the outcomes.
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient's clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The goal of dual antiplatelet therapy (DAPT) is to reduce the risk of stent thrombosis, a potentially life-threatening complication that can occur when blood clots form in the stent. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
This FAME 3 substudy aimed to define the value of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) and intravascular imaging for cardiovascular failure. In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Zsolt Piroth, TCT 2022: The value of measuring post-PCI FFR in patients with coronary artery disease
NEW
The impact of post-percutaneous coronary intervention (PCI) fractional flow reserve (FFR) has been assessed in patients with coronary artery disease (CAD). In this touchCARDIO interview, we speak with Dr Zsolt Piroth (Gottsegen National Cardiovascular Institute, Budapest, Hungary) to discuss the ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The PREDICT LAA trial aimed to examine whether cardiac computed tomography- based FEops HEARTguide™ computational modelling would benefit clinical outcomes when planning for left atrial appendage (LAA) closure. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
When performing percutaneous left atrial appendage (LAA) closure, challenges arise that impact clinical outcomes and cardiac computed tomography (CCT)- based patient-specific computational simulations provide device-host interactions. In this touchCARDIO interview, we speak with Dr Ole De Backer (Rigshospitalet, Copenhagen ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
NEW
The COPS trial aimed to assess the use of a cutting balloon technique in patients with calcified lesions. In this touchCARDIO interview, we speak with Dr Antonio Mangieri (Humanitas Research Hospital IRCCS, Rozzano, Milan, Italy) to discuss the challenges in ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
The bRIGHT study aimed to evaluate the safety and effectiveness of the TriClip device in symptomatic patients with severe tricuspid regurgitation. In this touchCARDIO interview, we speak with Professor Erwan Donal (University Hospital of Rennes, Rennes, France) to discuss tricuspid ...
Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
touchCARDIO spoke to Dr Duk-Woo Park (Asan Medical Center, Seoul, South Korea) to discuss his presentation at the American College of Cardiology Annual Meeting 2022, providing the results of the ADAPT-TAVR trial of edoxaban versus dual antiplatelet therapy for valve thrombosis ...
Mark CompleteCompleted
BookmarkBookmarked
touchCARDIO spoke to Prof Bon-Kwon Koo (Seoul National University College of Medicine, Seoul, South Korea) to discuss his presentation at the American College of Cardiology Annual Meeting 2022, providing the results of the FLAVOUR randomized clinical trial comparing fractional flow reserve-guided ...
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
